Theravance Biopharma Stock Price History
TBPH Stock | USD 9.51 0.21 2.16% |
If you're considering investing in Theravance Stock, it is important to understand the factors that can impact its price. As of today, the current price of Theravance Biopharma stands at 9.51, as last reported on the 7th of February, with the highest price reaching 9.76 and the lowest price hitting 9.33 during the day. Theravance Biopharma is out of control at the moment. Theravance Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0418, which indicates the firm had a 0.0418 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Theravance Biopharma, which you can use to evaluate the volatility of the company. Please validate Theravance Biopharma's Coefficient Of Variation of 1967.82, risk adjusted performance of 0.0492, and Semi Deviation of 2.21 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%.
Theravance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Theravance |
Sharpe Ratio = 0.0418
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | TBPH | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.77 actual daily | 24 76% of assets are more volatile |
Expected Return
0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Theravance Biopharma is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theravance Biopharma by adding it to a well-diversified portfolio.
Theravance Biopharma Stock Price History Chart
There are several ways to analyze Theravance Stock price data. The simplest method is using a basic Theravance candlestick price chart, which shows Theravance Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 24, 2025 | 10.47 |
Lowest Price | January 16, 2025 | 8.44 |
Theravance Biopharma February 7, 2025 Stock Price Synopsis
Various analyses of Theravance Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Theravance Stock. It can be used to describe the percentage change in the price of Theravance Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Theravance Stock.Theravance Biopharma Price Daily Balance Of Power | (0.49) | |
Theravance Biopharma Price Rate Of Daily Change | 0.98 | |
Theravance Biopharma Accumulation Distribution | 13,552 | |
Theravance Biopharma Price Action Indicator | (0.14) |
Theravance Biopharma February 7, 2025 Stock Price Analysis
Theravance Stock Price History Data
The price series of Theravance Biopharma for the period between Sat, Nov 9, 2024 and Fri, Feb 7, 2025 has a statistical range of 2.03 with a coefficient of variation of 4.47. The price distribution for the period has arithmetic mean of 9.49. The median price for the last 90 days is 9.57.Open | High | Low | Close | Volume | ||
02/06/2025 | 9.73 | 9.76 | 9.33 | 9.51 | 307,609 | |
02/05/2025 | 9.55 | 9.80 | 9.55 | 9.72 | 123,953 | |
02/04/2025 | 9.44 | 9.54 | 9.39 | 9.43 | 99,090 | |
02/03/2025 | 9.25 | 9.59 | 9.23 | 9.47 | 120,031 | |
01/31/2025 | 9.68 | 9.68 | 9.27 | 9.38 | 234,929 | |
01/30/2025 | 9.63 | 9.76 | 9.59 | 9.67 | 96,279 | |
01/29/2025 | 9.79 | 9.79 | 9.46 | 9.63 | 109,140 | |
01/28/2025 | 9.67 | 9.88 | 9.60 | 9.83 | 150,224 | |
01/27/2025 | 10.46 | 10.46 | 9.62 | 9.67 | 455,047 | |
01/24/2025 | 9.65 | 10.90 | 9.62 | 10.47 | 508,066 | |
01/23/2025 | 9.26 | 9.68 | 9.24 | 9.67 | 173,993 | |
01/22/2025 | 9.10 | 9.45 | 8.94 | 9.36 | 219,253 | |
01/21/2025 | 8.62 | 9.19 | 8.61 | 9.15 | 284,522 | |
01/17/2025 | 8.53 | 8.59 | 8.41 | 8.58 | 166,562 | |
01/16/2025 | 8.62 | 8.62 | 8.35 | 8.44 | 242,283 | |
01/15/2025 | 8.67 | 8.86 | 8.61 | 8.61 | 153,845 | |
01/14/2025 | 8.61 | 8.70 | 8.46 | 8.53 | 180,211 | |
01/13/2025 | 8.76 | 8.76 | 8.55 | 8.57 | 142,329 | |
01/10/2025 | 8.99 | 9.05 | 8.68 | 8.78 | 208,167 | |
01/08/2025 | 9.25 | 9.38 | 8.99 | 9.05 | 154,996 | |
01/07/2025 | 9.19 | 9.35 | 9.04 | 9.25 | 163,890 | |
01/06/2025 | 9.30 | 9.44 | 9.14 | 9.19 | 177,429 | |
01/03/2025 | 9.30 | 9.56 | 9.29 | 9.31 | 128,403 | |
01/02/2025 | 9.46 | 9.46 | 9.23 | 9.28 | 140,930 | |
12/31/2024 | 9.48 | 9.55 | 9.34 | 9.41 | 151,981 | |
12/30/2024 | 9.61 | 9.72 | 9.44 | 9.47 | 111,213 | |
12/27/2024 | 9.82 | 9.91 | 9.54 | 9.59 | 121,239 | |
12/26/2024 | 9.80 | 9.92 | 9.73 | 9.86 | 135,661 | |
12/24/2024 | 9.82 | 9.89 | 9.72 | 9.85 | 37,942 | |
12/23/2024 | 9.59 | 10.00 | 9.53 | 9.79 | 152,704 | |
12/20/2024 | 9.65 | 9.83 | 9.56 | 9.59 | 310,234 | |
12/19/2024 | 9.68 | 9.90 | 9.63 | 9.73 | 241,837 | |
12/18/2024 | 10.00 | 10.08 | 9.62 | 9.71 | 212,954 | |
12/17/2024 | 9.78 | 9.99 | 9.65 | 9.96 | 249,829 | |
12/16/2024 | 9.87 | 10.06 | 9.77 | 9.80 | 181,109 | |
12/13/2024 | 9.84 | 10.00 | 9.74 | 9.88 | 220,768 | |
12/12/2024 | 9.94 | 10.11 | 9.74 | 9.87 | 191,136 | |
12/11/2024 | 10.08 | 10.10 | 9.96 | 10.04 | 129,668 | |
12/10/2024 | 9.97 | 10.15 | 9.94 | 10.08 | 214,765 | |
12/09/2024 | 9.89 | 10.25 | 9.89 | 9.99 | 217,550 | |
12/06/2024 | 9.81 | 10.01 | 9.81 | 9.88 | 132,468 | |
12/05/2024 | 9.58 | 9.88 | 9.55 | 9.84 | 166,283 | |
12/04/2024 | 9.84 | 9.98 | 9.55 | 9.59 | 198,084 | |
12/03/2024 | 9.45 | 9.84 | 9.37 | 9.84 | 240,477 | |
12/02/2024 | 9.14 | 9.53 | 9.14 | 9.44 | 325,663 | |
11/29/2024 | 9.46 | 9.49 | 9.20 | 9.25 | 91,398 | |
11/27/2024 | 9.32 | 9.56 | 9.25 | 9.42 | 255,336 | |
11/26/2024 | 9.50 | 9.50 | 9.20 | 9.24 | 182,269 | |
11/25/2024 | 9.52 | 9.76 | 9.47 | 9.47 | 240,130 | |
11/22/2024 | 9.59 | 9.75 | 9.37 | 9.47 | 340,347 | |
11/21/2024 | 9.92 | 9.97 | 9.59 | 9.61 | 264,218 | |
11/20/2024 | 9.93 | 10.10 | 9.71 | 9.97 | 352,847 | |
11/19/2024 | 9.48 | 9.99 | 9.38 | 9.92 | 317,368 | |
11/18/2024 | 9.55 | 9.68 | 9.43 | 9.49 | 192,565 | |
11/15/2024 | 9.62 | 9.62 | 9.25 | 9.52 | 213,265 | |
11/14/2024 | 9.67 | 9.74 | 9.48 | 9.57 | 256,679 | |
11/13/2024 | 9.47 | 10.26 | 9.33 | 9.68 | 285,946 | |
11/12/2024 | 9.00 | 9.09 | 8.84 | 8.91 | 184,700 | |
11/11/2024 | 8.99 | 9.17 | 8.91 | 9.08 | 179,301 | |
11/08/2024 | 8.75 | 8.95 | 8.71 | 8.94 | 264,788 | |
11/07/2024 | 8.71 | 8.81 | 8.63 | 8.75 | 216,362 |
About Theravance Biopharma Stock history
Theravance Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theravance is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theravance Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theravance Biopharma stock prices may prove useful in developing a viable investing in Theravance Biopharma
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. Theravance Biopharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Theravance Bio is traded on NASDAQ Exchange in the United States.
Theravance Biopharma Stock Technical Analysis
Theravance Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Theravance Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theravance Biopharma's price direction in advance. Along with the technical and fundamental analysis of Theravance Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theravance to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0492 | |||
Jensen Alpha | 0.119 | |||
Total Risk Alpha | (0.16) | |||
Sortino Ratio | 0.0176 | |||
Treynor Ratio | 1.05 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Theravance Stock analysis
When running Theravance Biopharma's price analysis, check to measure Theravance Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theravance Biopharma is operating at the current time. Most of Theravance Biopharma's value examination focuses on studying past and present price action to predict the probability of Theravance Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theravance Biopharma's price. Additionally, you may evaluate how the addition of Theravance Biopharma to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |